leisure time -WSS

leisure time

author：hotspot 2025-09-03 03:28:10 - browse：6

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Medicaid, Medicare dual

explore

WSS

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

The struggle to figure out which patients 'deserve' Wegovy

Inequities make cancer less preventable for women: report

FDA seeks to regulate lab

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Free Covid tests will again be offered to all U.S. households

leisure time

leisure time

focus

Medicare proposal to cover medical devices draws a mixed reaction

Medicare drug price negotiation program allowed for now

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA weighs limits of animal data in assessing artificial wombs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Grad students accuse University of California of wage theft

Medicare proposal to cover medical devices draws a mixed reaction

Grad students accuse University of California of wage theft

Psychedelics group wrestles with new pharma identity

Transgender sports debate: Physicians say bans are health issue

Wikipedia

What happened to the House vote on health price transparency?

People with substance use disorder deserve online privacy

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Researchers use wearables data and AI to predict preterm birth risk

Data show record exodus of life scientists from academia

The struggle to figure out which patients 'deserve' Wegovy

explore

leisure time

hotspot

entertainment